Many clinical trial recruitment strategies focus solely on the business and technology aspects, neglecting the human element - what do our patients need, and are we build an engagement plan that meets their needs perfectly? Join us in this latest episode as Samantha Eells, a vision-driven entrepreneur with a background in epidemiology and over 15 years of experience conducting high-quality clinical research, will share her insights on working with sponsors and patients to implement an e...

Inclusive patient recruitment is crucial for advancing healthcare. By cultivating an inclusive landscape, healthcare professionals can better understand different communities' unique needs and challenges and develop solutions that work for everyone. In this latest episode, we will explore practical strategies and best practices for improving patient recruitment efforts with Alana Miller from Merck. From leveraging community partnerships, improving cultural competence, and implementing d...

Targeting a niche audience is a challenge. How do you stand out yet deliver quality leads? In today's episode, Dan Brenner, CEO of 1nHealth, shares his insights on creating targeted communications and effective campaigns to inspire positive reactions and actions to clinical trials. Listen to our podcast now. Are you a sponsor looking for technology solutions to democratize your trials? Visit our website at https://www.castoredc.com/ for more information

Clinical trials are evolving to meet the needs of patients and researchers alike. However, is the industry prepared to tackle emerging challenges in tech-enabled trials? In today's episode, our guest, Beth Hoffman, CEO of Origami Therapeutics, discusses these issues and gives insights on how they can be addressed. Listen to our latest podcast now for more info! Are you a sponsor looking for technology solutions to democratize your trials? Visit our website at https://www.castoredc...

Through the years, several apps and programs have been developed to aid clinical trials. However, the industry has taken quite a while to incorporate such technology. Is it time for the clinical trial world to step up its game? In today's episode, Michelle Wetherby, Tactile Medical's Director of Clinical Research, discusses how technological advancements have aided clinical trial improvements and advocated positive patient engagement. Take advantage of this learning and more! Listen to ...

In this episode of theSpark, Andy Lipetz and John Carlos Diaz, Clinical Research and Strategy Lead at GeoSera LLC, sit down and chat about his move from large pharma to small pharma, and ultimately started GeoSera Consulting. Covered in this Episode: The regulations from FDA and other regulatory bodies is not black or whiteClinical trials education and timing: why it’s crucial to get it right the first timeMaking your trial more attractive and winning at participation through reduced patient ...

In this episode of theSpark, Andy Lipetz sat down with Laura DeVries as she talks about how good business practices and good research methodologies are similar. You must first specify your variables, determine the inputs, and use consistent approaches. From here, you can refine your method by going back and making adjustments by measuring your outputs and establishing a feedback loop. Covered in this Episode: Attracting talent and building a career path in clinical trialsLeveraging on technol...

In this episode of theSpark, Kristin Stallcup had the opportunity to chat with Alina Gologan, Associate Clinical Research Manager at Nobel Biocare, as she talks about the many advancements made in the clinical trials space, but raising public awareness and bringing patients closer remains to be an area for opportunity. Covered in this Episode: Effective communication and information dissemination in the clinical trial space and what can be done to take it to the next levelThe decentralized ap...

In the short term, people tend to excessively exaggerate the influence of technology, while in the long term, they tend to underestimate it grossly. Although there has been some development, we have not gotten to the point where we've entirely changed the way we do trials. "As far as I can tell, the industry is considerably more sophisticated than ever when discussing the advancement of clinical trials today. I believe we must all work together to solve several problems." - Jacob LaPorte Ch...

Decentralized opportunities allow us to target underrepresented patients. Having greater inclusivity for patients helps gain trust and educate and help these patients. We have the opportunity to educate and help these patients in a way that feels safe, which can impact participation and give us richer data. Check out our first-ever theSpark Podcast episode, where we sat down with Kathleen Wisemandle, Aspire to Grow Coaching & Consulting LLC as she discusses Data Collection Procedures to B...